SCHEMBL12503522

SCHEMBL12503522

O=C(NC(=O)N1CCCC1c1ccccc1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.56
RIPK1 Q13546 1/20 0.56
GAA P10253 1/20 0.54
HSD11B1 P28845 2/20 0.53
HSP90AA1 P07900 1/20 0.49
HSP90AB1 P08238 1/20 0.49
PREP P48147 2/20 0.48
FAP Q12884 2/20 0.48
DPP4 P27487 1/20 0.48
CHRNB2 P17787 1/20 0.47
CHRNB4 P30926 1/20 0.47
CHRNA3 P32297 1/20 0.47
CHRNA7 P36544 1/20 0.47
CHRNA4 P43681 1/20 0.47
SCD5 Q86SK9 3/20 0.46
SCD O00767 1/20 0.46
POLB P06746 1/20 0.46
RECQL P46063 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12503519 0.82 POLB (0.70) GAAPREPFAPDPP4POLB
SCHEMBL1853141 0.78 RIPK1 (0.69) EPHX2RIPK1HSD11B1HSP90AA1HSP90AB1
SCHEMBL1847627 0.78 RIPK1 (0.69) EPHX2RIPK1HSD11B1HSP90AA1HSP90AB1
SCHEMBL17558248 0.78 RIPK1 (0.69) EPHX2RIPK1HSD11B1HSP90AA1HSP90AB1
SCHEMBL3511378 0.77 HCRTR1 (0.43) EPHX2GAAPREPFAPDPP4
SCHEMBL3513867 0.77 TRPV1 (0.52) GAAPREPFAPPOLB
SCHEMBL3062584 0.77 RIPK1 (0.67) EPHX2RIPK1HSD11B1HSP90AA1HSP90AB1
SCHEMBL8596155 0.76 PARP14 (0.62) RIPK1GAAHSD11B1HSP90AA1HSP90AB1
SCHEMBL28257267 0.75 HSD11B1 (0.61) EPHX2RIPK1HSD11B1HSP90AA1HSP90AB1
SCHEMBL21312423 0.75 RIPK1 (0.65) EPHX2RIPK1HSD11B1HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611441-A1 BACE INHIBITORS FOR USE IN THE TREATMENT OF DIABETES F.HOFFMANN-LA ROCHE AG (CH) 2013-07-10 EP disclosed
WO-2012028563-A1 BACE INHIBITORS FOR USE IN THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2012-03-08 WO disclosed